**CEFISAT-CV** combines Cefixime and Potassium Clavulanate, offering enhanced antibacterial action. Cefixime, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Clavulanic Acid, a beta-lactamase inhibitor, prevents bacterial resistance by protecting Cefixime from degradation. This synergy effectively treats a wide range of infections, including those of the respiratory and urinary tracts. It is crucial to adhere to prescribed dosages and medical guidance for optimal results.Available in PCD pharma franchise and Third Party manufacturing in saturn formulations